Share on StockTwits

Credit Suisse started coverage on shares of Envision Healthcare Holdings (NASDAQ:EVHC) in a report released on Tuesday. The firm set a “neutral” rating on the stock.

Shares of Envision Healthcare Holdings (NASDAQ:EVHC) opened at 35.88 on Tuesday. Envision Healthcare Holdings has a 52-week low of $24.62 and a 52-week high of $36.80. The stock’s 50-day moving average is $34.04 and its 200-day moving average is $33.27. The company has a market cap of $6.499 billion and a P/E ratio of 174.04.

Envision Healthcare Holdings (NASDAQ:EVHC) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.20 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.19 by $0.01. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the company posted ($0.03) earnings per share. The company’s quarterly revenue was up 14.2% on a year-over-year basis. On average, analysts predict that Envision Healthcare Holdings will post $1.12 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks downgraded shares of Envision Healthcare Holdings from an “outperform” rating to a “neutral” rating in a research note on Monday, May 12th. They now have a $38.60 price target on the stock. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Envision Healthcare Holdings in a research note on Thursday, May 8th. They now have a $40.00 price target on the stock, up previously from $39.00. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Envision Healthcare Holdings in a research note on Thursday, May 8th. They now have a $33.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Envision Healthcare Holdings currently has a consensus rating of “Buy” and a consensus price target of $47.78.

Envision Healthcare Holdings, Inc is a provider of physician-led, outsourced medical services in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.